skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:063143/0806   Pages: 4
Recorded: 03/22/2023
Conveyance: ASSIGNEE ADDRESS CHANGE
Total properties: 16
1
Patent #:
Issue Dt:
08/07/2007
Application #:
10682331
Filing Dt:
10/08/2003
Publication #:
Pub Dt:
11/18/2004
Title:
METHODS FOR TREATING POST-SURGICAL PAIN BY ADMINISTERING AN ANTI-NERVE GROWTH FACTOR ANTAGONIST
2
Patent #:
Issue Dt:
08/14/2007
Application #:
10682638
Filing Dt:
10/08/2003
Publication #:
Pub Dt:
07/12/2007
Title:
METHODS FOR TREATING POST-SURGICAL PAIN BY ADMINISTERING AN ANTI-NERVE GROWTH FACTOR ANTAGONIST ANTIBODY
3
Patent #:
Issue Dt:
11/11/2008
Application #:
10745775
Filing Dt:
12/24/2003
Publication #:
Pub Dt:
11/25/2004
Title:
ANTI-NGF ANTIBODIES AND METHODS USING SAME
4
Patent #:
Issue Dt:
09/24/2013
Application #:
11911305
Filing Dt:
07/15/2009
Publication #:
Pub Dt:
02/10/2011
Title:
Methods for Treating Osteoarthritis Pain By Administering a Nerve Growth Factor Antagonist and Compositions Containing the Same
5
Patent #:
Issue Dt:
12/15/2015
Application #:
13302264
Filing Dt:
11/22/2011
Publication #:
Pub Dt:
02/19/2015
Title:
ANTI-NGF ANTIBODIES AND METHODS USING SAME
6
Patent #:
Issue Dt:
12/27/2016
Application #:
13697683
Filing Dt:
01/17/2013
Publication #:
Pub Dt:
05/09/2013
Title:
HETERODIMERIC PROTEINS AND METHODS FOR PRODUCING AND PURIFYING THEM
7
Patent #:
Issue Dt:
05/17/2016
Application #:
13946580
Filing Dt:
07/19/2013
Publication #:
Pub Dt:
11/14/2013
Title:
METHODS FOR TREATING OSTEOARTHRITIS PAIN BY ADMINISTERING A NERVE GROWTH FACTOR ANTAGONIST AND COMPOSITIONS CONTAINING THE SAME
8
Patent #:
Issue Dt:
12/18/2018
Application #:
14958053
Filing Dt:
12/03/2015
Publication #:
Pub Dt:
06/09/2016
Title:
ANTI-PD-1 ANTIBODIES AND METHODS OF USE THEREOF
9
Patent #:
Issue Dt:
06/18/2019
Application #:
15287246
Filing Dt:
10/06/2016
Publication #:
Pub Dt:
03/30/2017
Title:
METHODS FOR TREATING OSTEOARTHRISTIS PAIN BY ADMINISTERING A NERVE GROWTH FACTOR ANTAGONIST AND COMPOSITIONS CONTAINING THE SAME
10
Patent #:
Issue Dt:
11/27/2018
Application #:
15351275
Filing Dt:
11/14/2016
Publication #:
Pub Dt:
03/02/2017
Title:
HETERODIMERIC PROTEINS AND METHODS FOR PRODUCING AND PURIFYING THEM
11
Patent #:
Issue Dt:
07/19/2022
Application #:
16157951
Filing Dt:
10/11/2018
Publication #:
Pub Dt:
04/04/2019
Title:
HETERODIMERIC PROTEINS AND METHODS FOR PRODUCING AND PURIFYING THEM
12
Patent #:
Issue Dt:
05/26/2020
Application #:
16188120
Filing Dt:
11/12/2018
Publication #:
Pub Dt:
03/21/2019
Title:
ANTI-PD-1 ANTIBODIES AND METHODS OF USE THEREOF
13
Patent #:
Issue Dt:
12/14/2021
Application #:
16488040
Filing Dt:
08/22/2019
Publication #:
Pub Dt:
01/30/2020
Title:
ANTI-GITR ANTIBODIES AND METHODS OF USE THEREOF
14
Patent #:
Issue Dt:
05/24/2022
Application #:
16847229
Filing Dt:
04/13/2020
Publication #:
Pub Dt:
11/26/2020
Title:
ANTI-PD-1 ANTIBODIES AND METHODS OF USE THEREOF
15
Patent #:
NONE
Issue Dt:
Application #:
17725199
Filing Dt:
04/20/2022
Publication #:
Pub Dt:
08/11/2022
Title:
ANTI-PD-1 ANTIBODIES AND METHODS OF USE THEREOF
16
Patent #:
NONE
Issue Dt:
Application #:
17846933
Filing Dt:
06/22/2022
Publication #:
Pub Dt:
10/20/2022
Title:
HETERODIMERIC PROTEINS AND METHODS FOR PRODUCING AND PURIFYING THEM
Assignor
1
Exec Dt:
03/07/2023
Assignee
1
66 HUDSON BOULEVARD EAST
LEGAL PATENT DEPT, CHIEF IP COUNSEL
NEW YORK, NEW YORK 10001-2192
Correspondence name and address
PFIZER INC.
66 HUDSON BOULEVARD EAST
LEGAL PATENT DEPT, CHIEF IP COUNSEL
NEW YORK, NY 10001-2192

Search Results as of: 06/06/2024 10:41 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT